Teligent Debt to Equity Ratio 2012-2021 | TLGT
Current and historical debt to equity ratio values for Teligent (TLGT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Teligent debt/equity for the three months ending June 30, 2021 was 0.00.
| Teligent Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-06-30 | $0.13B | $-0.04B | -3.08 |
| 2021-03-31 | $0.13B | $-0.03B | -4.12 |
| 2020-12-31 | $0.20B | $-0.11B | -1.80 |
| 2020-09-30 | $0.23B | $-0.04B | -5.75 |
| 2020-06-30 | $0.23B | $-0.04B | -6.04 |
| 2020-03-31 | $0.22B | $-0.03B | -6.87 |
| 2019-12-31 | $0.21B | $-0.01B | -39.99 |
| 2019-09-30 | $0.20B | $0.00B | -1266.76 |
| 2019-06-30 | $0.19B | $0.01B | 28.11 |
| 2019-03-31 | $0.18B | $0.01B | 17.77 |
| 2018-12-31 | $0.17B | $0.02B | 9.36 |
| 2018-09-30 | $0.16B | $0.04B | 4.40 |
| 2018-06-30 | $0.15B | $0.04B | 3.83 |
| 2018-03-31 | $0.14B | $0.04B | 3.49 |
| 2017-12-31 | $0.14B | $0.05B | 3.13 |
| 2017-09-30 | $0.14B | $0.05B | 2.85 |
| 2017-06-30 | $0.14B | $0.06B | 2.36 |
| 2017-03-31 | $0.13B | $0.06B | 2.26 |
| 2016-12-31 | $0.13B | $0.06B | 2.23 |
| 2016-09-30 | $0.13B | $0.06B | 2.03 |
| 2016-06-30 | $0.12B | $0.06B | 1.94 |
| 2016-03-31 | $0.12B | $0.07B | 1.83 |
| 2015-12-31 | $0.11B | $0.07B | 1.71 |
| 2015-09-30 | $0.12B | $0.07B | 1.58 |
| 2015-06-30 | $0.12B | $0.08B | 1.61 |
| 2015-03-31 | $0.15B | $0.05B | 3.30 |
| 2014-12-31 | $0.16B | $0.04B | 4.04 |
| 2014-09-30 | $0.02B | $0.03B | 0.45 |
| 2014-06-30 | $0.01B | $0.01B | 0.96 |
| 2014-03-31 | $0.01B | $0.01B | 0.85 |
| 2013-12-31 | $0.01B | $0.01B | 1.15 |
| 2013-09-30 | $0.01B | $0.01B | 0.95 |
| 2013-06-30 | $0.01B | $0.01B | 0.77 |
| 2013-03-31 | $0.00B | $0.01B | 0.70 |
| 2012-12-31 | $0.00B | $0.01B | 0.47 |
| 2012-09-30 | $0.00B | $0.01B | 0.46 |
| 2012-06-30 | $0.00B | $0.01B | 0.31 |
| 2012-03-31 | $0.00B | $0.01B | 0.31 |
| 2011-12-31 | $0.00B | $0.01B | 0.24 |
| 2011-09-30 | $0.00B | $0.01B | 0.19 |
| 2011-06-30 | $0.00B | $0.01B | 0.17 |
| 2011-03-31 | $0.00B | $0.01B | 0.17 |
| 2010-12-31 | $0.00B | $0.01B | 0.10 |
| 2010-09-30 | $0.00B | $0.00B | 0.27 |
| 2010-06-30 | $0.00B | $0.01B | 0.28 |
| 2010-03-31 | $0.00B | $0.01B | 0.25 |
| 2009-12-31 | $0.00B | $0.01B | 0.21 |
| 2009-09-30 | $0.00B | $0.01B | 0.20 |
| 2009-06-30 | $0.00B | $0.01B | 0.21 |
| 2009-03-31 | $0.01B | $0.00B | 1.66 |
| 2008-12-31 | $0.00B | $0.00B | 0.50 |
| 2008-09-30 | $0.00B | $0.00B | 0.40 |
| 2008-06-30 | $0.00B | $0.00B | 0.30 |
| 2008-03-31 | $0.00B | $0.00B | 0.27 |
| 2007-12-31 | $0.00B | $0.00B | 0.37 |
| 2007-09-30 | $0.00B | $0.00B | 0.50 |
| 2007-06-30 | $0.00B | $0.00B | 0.55 |
| 2007-03-31 | $0.00B | $0.00B | 0.60 |
| 2006-12-31 | $0.00B | $0.00B | 1.35 |
| 2006-09-30 | $0.00B | $0.00B | 0.92 |
| 2006-06-30 | $0.00B | $0.00B | 0.82 |
| 2006-03-31 | $0.00B | $0.00B | 0.64 |
| 2005-12-31 | $0.00B | $0.00B | 0.53 |
| 2005-09-30 | $0.00B | $0.00B | 0.22 |
| 2005-06-30 | $0.00B | $0.00B | 0.24 |
| 2005-03-31 | $0.00B | $0.00B | 0.23 |
| 2004-12-31 | $0.00B | $0.00B | 0.18 |
| 2004-09-30 | $0.00B | $0.00B | 0.18 |
| 2004-06-30 | $0.00B | $0.00B | 0.20 |
| 2004-03-31 | $0.00B | $0.00B | 0.19 |
| 2003-12-31 | $0.00B | $0.00B | 0.20 |
| 2003-09-30 | $0.00B | $0.00B | 0.29 |
| 2003-06-30 | $0.00B | $0.00B | 0.30 |
| 2003-03-31 | $0.00B | $0.01B | 0.26 |
| 2002-12-31 | $0.00B | $0.01B | 0.32 |
| 2002-09-30 | $0.00B | $0.00B | 0.73 |
| 2002-06-30 | $0.00B | $0.01B | 0.68 |
| 2002-03-31 | $0.02B | $-0.01B | -3.18 |
| 2001-12-31 | $0.02B | $0.00B | -3.40 |
| 2001-09-30 | $0.02B | $0.00B | -4.21 |
| 2001-06-30 | $0.02B | $0.00B | -5.38 |
| 2001-03-31 | $0.02B | $0.00B | -4.10 |
| 2000-12-31 | $0.02B | $0.00B | -4.79 |
| 2000-09-30 | $0.02B | $0.00B | -7.86 |
| 2000-06-30 | $0.04B | $0.01B | 4.09 |
| 2000-03-31 | $0.03B | $0.01B | 6.55 |
| 1999-12-31 | $0.03B | $0.01B | 5.12 |
| 1999-09-30 | $0.03B | $0.01B | 4.83 |
| 1999-06-30 | $0.03B | $0.01B | 4.74 |
| 1999-03-31 | $0.03B | $0.01B | 4.75 |
| 1998-12-31 | $0.03B | $0.01B | 4.41 |
| 1998-09-30 | $0.03B | $0.01B | 3.92 |
| 1998-06-30 | $0.03B | $0.01B | 3.74 |
| 1998-03-31 | $0.03B | $0.01B | 3.23 |
| 1997-12-31 | $0.03B | $0.01B | 3.09 |
| 1997-09-30 | $0.02B | $0.01B | 2.02 |
| 1997-06-30 | $0.02B | $0.01B | 2.11 |
| 1997-03-31 | $0.02B | $0.01B | 2.22 |
| 1996-12-31 | $0.03B | $0.01B | 2.49 |
| 1996-09-30 | $0.02B | $0.01B | 2.44 |
| 1996-06-30 | $0.02B | $0.01B | 2.46 |
| 1996-03-31 | $0.02B | $0.01B | 2.75 |
| 1995-12-31 | $0.02B | $0.01B | 2.78 |
| 1995-09-30 | $0.02B | $0.02B | 1.16 |
| 1995-06-30 | $0.02B | $0.02B | 1.07 |
| 1995-03-31 | $0.02B | $0.02B | 0.93 |
| 1994-12-31 | $0.02B | $0.01B | 1.23 |
| 1994-09-30 | $0.02B | $0.01B | 1.19 |
| 1994-06-30 | $0.02B | $0.01B | 1.19 |
| 1994-03-31 | $0.01B | $0.01B | 1.14 |
| 1993-12-31 | $0.01B | $0.01B | 1.11 |
| 1993-09-30 | $0.01B | $0.02B | 0.79 |
| 1993-06-30 | $0.01B | $0.02B | 0.91 |
| 1993-03-31 | $0.01B | $0.02B | 0.85 |
| 1992-12-31 | $0.01B | $0.02B | 0.80 |
| 1992-09-30 | $0.01B | $0.02B | 0.71 |
| 1992-06-30 | $0.01B | $0.02B | 0.83 |
| 1992-03-31 | $0.01B | $0.02B | 0.75 |
| 1991-12-31 | $0.01B | $0.01B | 0.82 |
| 1991-09-30 | $0.01B | $0.01B | 1.09 |
| 1991-06-30 | $0.01B | $0.01B | 1.10 |
| 1991-03-31 | $0.01B | $0.01B | 1.08 |
| 1990-12-31 | $0.01B | $0.01B | 1.05 |
| 1990-09-30 | $0.01B | $0.01B | 1.17 |
| 1990-06-30 | $0.01B | $0.01B | 1.22 |
| 1990-03-31 | $0.01B | $0.01B | 1.21 |
| 1989-12-31 | $0.01B | $0.01B | 1.27 |
| 1989-09-30 | $0.01B | $0.01B | 1.02 |
| 1989-06-30 | $0.01B | $0.01B | 1.03 |
| 1989-03-31 | $0.01B | $0.01B | 1.04 |
| 1988-12-31 | $0.01B | $0.01B | 1.03 |
| 1988-09-30 | $0.01B | $0.01B | 0.69 |
| 1988-06-30 | $0.01B | $0.01B | 0.76 |
| 1988-03-31 | $0.01B | $0.01B | 0.77 |
| 1987-12-31 | $0.01B | $0.01B | 1.09 |
| 1987-09-30 | $0.01B | $0.01B | 0.90 |
| 1987-06-30 | $0.01B | $0.01B | 0.96 |
| 1987-03-31 | $0.01B | $0.01B | 1.08 |
| 1986-12-31 | $0.01B | $0.01B | 1.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |